1,033
Views
39
CrossRef citations to date
0
Altmetric
Review Articles

The development and hepatotoxicity of acetaminophen: reviewing over a century of progress

&
Pages 472-500 | Received 28 Sep 2020, Accepted 30 Sep 2020, Published online: 14 Oct 2020

References

  • Abdelmegeed MA, Jang S, Banerjee A, Hardwick JP, Song BJ. 2013. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury. Free Radic Biol Med. 60:211–222.
  • Agarwal R, Hennings L, Rafferty TM, Letzig LG, McCullough S, James LP, MacMillan-Crow LA, Hinson JA. 2012. Acetaminophen-induced hepatotoxicity and protein nitration in neuronal nitric-oxide synthase knockout mice. J Pharmacol Exp Ther. 340(1):134–142.
  • Agarwal R, MacMillan-Crow LA, Rafferty T, Saba H, Hinson JA. 2010. Acetaminophen-induced alterations in hepatic mitochondrial manganese superoxide dismutase (MnSOD; SOD2) activity in mice. Exp Biol. C45:225.
  • Akakpo JY, Ramachandran A, Duan L, Schaich MA, Jaeschke MW, Freudenthal BD, Ding WX, Rumack BH, Jaeschke H. 2019. Delayed treatment with 4-methylpyrazole protects against acetaminophen hepatotoxicity in mice by inhibition of c-Jun n-terminal kinase. Toxicol Sci. 170(1):57–68.
  • Akakpo JY, Ramachandran A, Kandel SE, Ni HM, Kumer SC, Rumack BH, Jaeschke H. 2018. 4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes. Hum Exp Toxicol. 37(12):1310–1322.
  • Andersson BS, Rundgren M, Nelson SD, Harder S. 1990. N-acetyl-p-benzoquinone imine-induced changes in the energy metabolism in hepatocytes. Chem Biol Interact. 75(2):201–211.
  • Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, Monga SP. 2009. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol. 175(3):1056–1065.
  • Baines CP, Gutiérrez-Aguilar M. 2018. The still uncertain identity of the channel-forming unit(s) of the mitochondrial permeability transition pore. Cell Calcium. 73:121–130.
  • Bajt ML, Cover C, Lemasters JJ, Jaeschke H. 2006. Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. Toxicol Sci. 94(1):217–225.
  • Bajt ML, Knight TR, Farhood A, Jaeschke H. 2003. Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther. 307(1):67–73.
  • Bajt ML, Ramachandran A, Yan HM, Lebofsky M, Farhood A, Lemasters JJ, Jaeschke H. 2011. Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci. 122(2):598–605.
  • Banerjee S, Melnyk SB, Krager KJ, Aykin-Burns N, Letzig LG, James LP, Hinson JA. 2015. The neuronal nitric oxide synthase inhibitor NANT blocks acetaminophen toxicity and protein nitration in freshly isolated hepatocytes. Free Radic Biol Med. 89:750–757.
  • Banerjee S, Melnyk SB, Krager KJ, Aykin-Burns N, McCullough SS, James LP, Hinson JA. 2017. Trifluoperazine inhibits acetaminophen-induced hepatotoxicity and hepatic reactive nitrogen formation in mice and in freshly isolated hepatocytes. Toxicol Rep. 4:134–142.
  • Bartolone JB, Birge RB, Sparks K, Cohen SD, Khairallah EA. 1988. Immunochemical analysis of acetaminophen covalent binding to proteins. Partial characterization of the major acetaminophen-binding liver proteins. Biochem Pharmacol. 37(24):4763–4774.
  • Bartolone JB, Sparks K, Cohen SD, Khairallah EA. 1987. Immunochemical detection of acetaminophen-bound liver proteins. Biochem Pharmacol. 36(8):1193–1196.
  • Bateman DN, Dear JW. 2019. Acetylcysteine in paracetamol poisoning: a perspective of 45 years of use. Toxicol Res. 8(4):489–498.
  • Beckman JS, Koppenol WH. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 271(5 Pt 1):C1424–C1437.
  • Beckman JS. 2009. Understanding peroxynitrite biochemistry and its potential for treating human diseases. Arch Biochem Biophys. 484(2):114–116.
  • Bedda S, Laurent A, Conti F, Chéreau C, Tran A, Tran-Van Nhieu J, Jaffray P, Soubrane O, Goulvestre C, Calmus Y, et al. 2003. Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol. 39(5):765–772.
  • Bessems JGM, Vermeulen NPE. 2001. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 31(1):55–138.
  • Bhattacharyya S, Pence L, Beger R, Chaudhuri S, McCullough S, Yan K, Simpson P, Hennings L, Hinson J, James L. 2013. Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites. 3(3):606–622.
  • Bhattacharyya S, Yan K, Pence L, Simpson PM, Gill P, Letzig LG, Beger RD, Sullivan JE, Kearns GL, Reed MD, et al. 2014. Targeted liquid chromatography–mass spectrometry analysis of serum acylcarnitines in acetaminophen toxicity in children. Biomark Med. 8(2):147–159.
  • Bhushan B, Gunewardena S, Edwards G, Apte U. 2020. Comparison of liver regeneration after partial hepatectomy and acetaminophen-induced acute liver failure: a global picture based on transcriptome analysis. Food Chem Toxicol. 139:111186.
  • Bhushan B, Poudel S, Manley MW Jr, Roy N, Apte U. 2017. Inhibition of glycogen synthase kinase 3 accelerated liver regeneration after acetaminophen-induced hepatotoxicity in mice. Am J Pathol. 187(3):543–552.
  • Bhushan B, Walesky C, Manley M, Gallagher T, Borude P, Edwards G, Monga SP, Apte U. 2014. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. Am J Pathol. 184(11):3013–3025.
  • Boobis AR, Seddon CE, Nasseri-Sina P, Davies DS. 1990. Evidence for a direct role of intracellular calcium in paracetamol toxicity. Biochem Pharmacol. 39(8):1277–1281.
  • Boobis AR, Tee LB, Hampden CE, Davies DS. 1986. Freshly isolated hepatocytes as a model for studying the toxicity of paracetamol. Food Chem Toxicol. 24(6–7):731–736.
  • Bourdi M, Davies JS, Pohl LR. 2011. Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury. Chem Res Toxicol. 24(6):794–796.
  • Bourdi M, Korrapati MC, Chakraborty M, Yee SB, Pohl LR. 2008. Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochem Biophys Res Commun. 374(1):6–10.
  • Boyd EM, Bereczky GM. 1966. Liver necrosis from paracetamol. Br J Pharmacol Chemother. 26(3):606–614.
  • Boyer TD, Rouff SL. 1971. Acetaminophen-induced hepatic necrosis and renal failure. JAMA. 218(3):440–441.
  • Brennan RJ, Mankes RF, Lefevre R, Raccio-Robak N, Baevsky RH, DelVecchio JA, Zink BJ. 1994. 4-Methylpyrazole blocks acetaminophen hepatotoxicity in the rat. Ann Emerg Med. 23(3):487–494.
  • Brodie BB, Axelrod J. 1949. The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther. 97(1):58–67.
  • Buckpitt AR, Rollins DE, Mitchell JR. 1979. Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation. Biochem Pharmacol. 28(19):2941–2946.
  • Bulera SJ, Cohen SD, Khairallah EA. 1996. Acetaminophen-arylated proteins are detected in hepatic subcellular fractions and numerous extra-hepatic tissues in CD-1 and C57B1/6J mice. Toxicology. 109(2–3):85–99.
  • Burcham PC, Harman AW. 1988. Effect of acetaminophen hepatotoxicity on hepatic mitochondrial and microsomal calcium contents in mice. Toxicol Lett. 44(1–2):91–99.
  • Burcham PC, Harman AW. 1991. Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J Biol Chem. 266(8):5049–5054.
  • Burk RF, Hill KE, Hunt RJ, Martin AE. 1990. Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res Commun Chem Pathol Pharmacol. 69(1):115–118.
  • Cahn A, Hepp P. 1886. Das antifebrin, ein neues fiebermittel. Zentralblatt Fur Klinische Medizin. 7:561–564.
  • Calder IC, Creek MJ, Williams PJ, Funder CC, Green CR, Ham KN, Tange JD. 1973. N-Hydroxylation of p-acetophenetidide as a factor in nephrotoxicity. J Med Chem. 16(5):499–502.
  • Calder IC, Creek MJ, Williams PJ. 1974. N-hydroxyphenacetinn as a precursor of 3-substituted 4-hydroxyacetanilide metabolites of phenacetin. Chem Biol Interact. 8(2):87–90.
  • Calder IC, Hart SJ, Healey K, Ham KN. 1981. N-hydroxyacetaminophen: a postulated toxic metabolite of acetaminophen. J Med Chem. 24(8):988–993.
  • Chan K, Han XD, Kan YW. 2001. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci U S A. 98(8):4611–4616.
  • Chaudhuri S, McCullough SS, Hennings L, Brown AT, Li SH, Simpson PM, Hinson JA, James LP. 2012. Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice. Toxicol Appl Pharmacol. 264(2):192–201.
  • Chen WQ, Shockcor JP, Tonge R, Hunter A, Gartner C, Nelson SD. 1999. Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel Ipso adduct. Biochemistry. 38(25):8159–8166.
  • Chen Y, Liu K, Zhang J, Hai Y, Wang P, Wang H, Liu Q, Wong CC, Yao J, Gao Y, et al. 2020. c-Jun NH2-terminal protein kinase phosphorylates the Nrf2-ECH homology 6 domain of nuclear factor erythroid 2-related factor 2 and downregulates cytoprotective genes in acetaminophen-induced liver injury in mice. Hepatology. 71(5):1787–1801.
  • Chiew AL, James LP, Isbister GK, Pickering JW, McArdle K, Chan BSH, Buckley NA. 2020. Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5). J Hepatol. 72(3):450–462.
  • Clemens MM, Kennon-McGill S, Apte U, James LP, Finck BN, McGill MR. 2019. The inhibitor of glycerol 3-phosphate acyltransferase FSG67 blunts liver regeneration after acetaminophen overdose by altering GSK3β and Wnt/β-catenin signaling. Food Chem Toxicol. 125:279–288.
  • Clemens MM, McGill MR, Apte U. 2019. Mechanisms and biomarkers of liver regeneration after drug-induced liver injury. Adv Pharmacol. 85:241–262.
  • Cohen SD, Khairallah EA. 1997. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev. 29(1–2):59–77.
  • Coles B, Wilson I, Wardman P, Hinson JA, Nelson SD, Ketterer B. 1988. The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys. 264(1):253–260.
  • Copple IM, Goldring CE, Jenkins RE, Chia AJ, Randle LE, Hayes JD, Kitteringham NR, Park BK. 2008. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. Hepatology. 48(4):1292–1301.
  • Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC. 1980. Evidence that acetaminophen and n-hydroxyacetaminophen form a common arylating intermediate, n-acetyl-para-benzoquinoneimine. Mol Pharmacol. 18(3):536–542.
  • Corcoran GB, Wong BK, Neese BL. 1987. Early sustained rise in total liver calcium during acetaminophen hepatotoxicity in mice. Res Commun Chem Pathol Pharmacol. 58(3):291–305.
  • Coriat R, Leconte M, Kavian N, Bedda S, Nicco C, Chereau C, Goulvestre C, Weill B, Laurent A, Batteux F. 2011. Mangafodipir protects against hepatic ischemia–reperfusion injury in mice. PLoS One. 6(11):e27005.
  • Cover C, Mansouri A, Knight TR, Bajt ML, Lemasters JJ, Pessayre D, Jaeschke H. 2005. Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity. J Pharmacol Exp Ther. 315(2):879–887.
  • Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. 2012. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 73(2):285–294.
  • Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. 2011. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int. 31(8):1127–1136.
  • Cubero FJ, Zoubek ME, Hu W, Peng J, Zhao G, Nevzorova YA, Al Masaoudi M, Bechmann LP, Boekschoten MV, Muller M, et al. 2016. Combined activities of JNK1 and JNK2 in hepatocytes protect against toxic liver injury. Gastroenterology. 150(4):968–981.
  • Dahlin DC, Miwa GT, Lu AYH, Nelson SD. 1984. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA. 81(5):1327–1331.
  • Dahlin DC, Nelson SD. 1982. Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J Med Chem. 25(8):885–886.
  • Dara L, Johnson H, Suda J, Win S, Gaarde W, Han D, Kaplowitz N. 2015. Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis. Hepatology. 62(6):1847–1857.
  • Davern TJ 2nd, James LP, Hinson JA, Polson J, Larson AM, Fontana RJ, Lalani E, Munoz S, Shakil AO, Lee WM. 2006. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology. 130(3):687–694.
  • Davidson DG, Eastham WN. 1966. Acute liver necrosis following overdose of paracetamol. Br Med J. 2(5512):497–499.
  • Davis M, Ideo G, Harrison NG, Williams R. 1975. Hepatic glutathione depletion and impaired bromosulphthalein clearance early after paracetamol overdose in man and the rat. Clin Sci Mol Med. 49(5):495–502.
  • Deutsch M, Graffeo CS, Rokosh R, Pansari M, Ochi A, Levie EM, Van Heerden E, Tippens DM, Greco S, Barilla R, et al. 2015. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death Dis. 6(5):e1759.
  • Dimova S, Koleva M, Rangelova D, Stoythchev T. 1995. Effect of nifedipine, verapamil, diltiazem and trifluoperazine on acetaminophen toxicity in mice. Arch Toxicol. 70(2):112–118.
  • Dixon MF, Nimmo J, Prescott LF. 1971. Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol. 103(4):225–229.
  • Donahower BC, McCullough SS, Hennings L, Simpson PM, Stowe CD, Saad AG, Kurten RC, Hinson JA, James LP. 2010. Human recombinant vascular endothelial growth factor reduces necrosis and enhances hepatocyte regeneration in a mouse model of acetaminophen toxicity. J Pharmacol Exp Ther. 334(1):33–43.
  • Donnelly PJ, Walker RM, Racz WJ. 1994. Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity. Arch Toxicol. 68(2):110–118.
  • Du K, Ramachandran A, McGill MR, Mansouri A, Asselah T, Farhood A, Woolbright BL, Ding WX, Jaeschke H. 2017. Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity. Food Chem Toxicol. 108(Pt A):339–350.
  • Du K, Xie Y, McGill MR, Jaeschke H. 2015. Pathophysiological significance of c-Jun N-terminal kinase in acetaminophen hepatotoxicity. Expert Opin Drug Metab Toxicol. 11(11):1769–1779.
  • Duan L, Woolbright BL, Jaeschke H, Ramachandran A. 2020. Late protective effect of netrin-1 in the murine acetaminophen hepatotoxicity model. Toxicol Sci. 175(2):168–181.
  • Kheradpezhouha E, Ma L, Morphettb A, Barrittb GJ, Rychkova GY. 2014. TRPM2 channels mediate acetaminophen-induced liver damage. Proc Natl Acad Sci USA. 111(8):3176–3181.
  • Elsby R, Kitteringham NR, Goldring CE, Lovatt CA, Chamberlain M, Henderson CJ, Wolf CR, Park BK. 2003. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem. 278(25):22243–22249.
  • Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T, Harada T, Yamamoto M. 2001. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci. 59(1):169–177.
  • Feng D, Wang Y, Wang H, Weng H, Kong X, Martin-Murphy BV, Li Y, Park O, Dooley S, Ju C, et al. 2014. Acute and chronic effects of IL-22 on acetaminophen-induced liver injury. J Immunol. 193(5):2512–2518.
  • Flinn FB, Brodie BB. 1948. The effect on the pain threshold of N-acetyl p-aminophenol, a product derived in the body from acetanilide. J Pharmacol Exp Ther. 94(1):76.
  • Forte AJ, Wilson JM, Slattery JT, Nelson SD. 1984. The formation and toxicity of catechol metabolites of acetaminophen in mice. Drug Metab Dispos. 12(4):484–491.
  • Gao RY, Wang M, Liu Q, Feng D, Wen Y, Xia Y, Colgan SP, Eltzschig HK, Ju C. 2020. Hypoxia-inducible factor-2α reprograms liver macrophages to protect against acute liver injury through the production of interleukin-6. Hepatology. 71(6):2105–2117.
  • Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, et al. 2004. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology. 39(5):1267–1276.
  • Greenberg LA, Lester D. 1947. The metabolic fate of acetanilid and other aniline derivatives; the role of p-aminophenol in the production of methemoglobinemia after acetanilid. J Pharmacol Exp Ther. 90(2):150–153.
  • Gujral JS, Knight TR, Farhood A, Bajt ML, Jaeschke H. 2002. Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci. 67(2):322–328.
  • Gunawan BK, Liu ZX, Han D, Hanawa N, Gaarde WA, Kaplowitz N. 2006. c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology. 131(1):165–178.
  • Halmes NC, Hinson JA, Martin BA, Pumford NR. 1995. Purification and characterization of a 50 kDa hepatic mitochondrial protein which covalently binds to a reactive metabolite of acetaminophen. ISSX Proceedings.
  • Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N. 2008. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 283(20):13565–13577.
  • Hardwick SJ, Wilson JW, Fawthrop DJ, Boobis AR, Davies DS. 1992. Paracetamol toxicity in hamster isolated hepatocytes: the increase in cytosolic calcium accompanies, rather than precedes, loss of viability. Arch Toxicol. 66(6):408–412.
  • Hart SG, Cartun RW, Wyand DS, Khairallah EA, Cohen SD. 1995. Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity. Fundam Appl Toxicol. 24(2):260–274.
  • Harvison PJ, Guengerich FP, Rashed MS, Nelson SD. 1988. Cytochrome-p-450 isozyme selectivity in the oxidation of acetaminophen. Chem Res Toxicol. 1(1):47–52.
  • Henderson CJ, Wolf CR, Kitteringham N, Powell H, Otto D, Park BK. 2000. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci USA. 97(23):12741–12745.
  • Henderson NC, Pollock KJ, Frew J, Mackinnon AC, Flavell RA, Davis RJ, Sethi T, Simpson KJ. 2007. Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut. 56(7):982–990.
  • Hinson JA, Michael SL, Ault SG, Pumford NR. 2000. Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice. Toxicol Sci. 53(2):467–473.
  • Hinson JA, Mitchell JR, Jollow DJ. 1976. N-hydroxylation of p-chloroacetanilde in hamsters. Biochem Pharmacol. 25(5):599–601.
  • Hinson JA, Mitchell JR. 1976. N-Hydroxylation of phenacetin by hamster liver microsomes. Drug Metab Dispos. 4(5):430–435.
  • Hinson JA, Monks TJ, Hong M, Highet RJ, Pohl LR. 1982. 3-(Glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen. Drug Metab Dispos. 10(1):47–50.
  • Hinson JA, Nelson SD, Gillette JR. 1979. Metabolism of [p-18O]-phenacetin: the mechanism of activation of phenacetin to reactive metabolites in hamsters. Mol Pharmacol. 15(2):419–427.
  • Hinson JA, Nelson SD, Mitchell JR. 1977. Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Mol Pharmacol. 13(4):625–633.
  • Hinson JA, Pike SL, Pumford NR, Mayeux PR. 1998. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol. 11(6):604–607.
  • Hinson JA, Pohl LR, Gillette JR. 1979. N-Hydroxyacetaminophen: a microsomal metabolite of N-hydroxyphenacetin but apparently not of acetaminophen. Life Sci. 24(23):2133–2138.
  • Hinson JA, Pohl LR, Gillette JR. 1980. A simple high-pressure liquid chromatographic assay for the N-hydroxy derivatives of phenacetin, acetaminophen, 2-acetylaminofluorene, and other hydroxamic acids. Anal Biochem. 101(2):462–467.
  • Hinson JA, Pohl LR, Monks TJ, Gillette JR, Guengerich FP. 1980. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metab Dispos. 8(5):289–294.
  • Hinson JA, Pumford NR, Roberts DW. 1995. Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev. 27(1–2):73–92.
  • Hinson JA, Roberts DW, Benson RW, Dalhoff K, Loft S, Poulsen HE. 1990. Mechanism of paracetamol toxicity. Lancet. 335(8691):732.
  • Hinson JA. 1980. Biochemical toxicology of acetaminophen. Rev Biochem Toxicol. 2:103–129.
  • Hoivik DJ, Manautou JE, Tveit A, Mankowski DC, Khairallah EA, Cohen SD. 1996. Evidence suggesting the 58-kDa acetaminophen binding protein is a preferential target for acetaminophen electrophile. Fundam Appl Toxicol. 32(1):79–86.
  • Holt MP, Cheng L, Ju C. 2008. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol. 84(6):1410–1421.
  • Hu J, Kholmukhamedov A, Lindsey CC, Beeson CC, Jaeschke H, Lemasters JJ. 2016. Translocation of iron from lysosomes to mitochondria during acetaminophen-induced hepatocellular injury: protection by starch-desferal and minocycline. Free Radic Biol Med. 97:418–426.
  • Hu J, Lemasters JJ. 2020. Suppression of iron mobilization from lysosomes to mitochondria attenuates liver injury after acetaminophen overdose in vivo in mice: protection by minocycline. Toxicol Appl Pharmacol. 392:114930.
  • Igusa Y, Yamashina S, Izumi K, Inami Y, Fukada H, Komatsu M, Tanaka K, Ikejima K, Watanabe S. 2012. Loss of autophagy promotes murine acetaminophen hepatotoxicity. J Gastroenterol. 47(4):433–443.
  • Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ. 2009. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest. 119(2):305–314.
  • Ito Y, Bethea NW, Abril ER, McCuskey RS. 2003. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation. 10(5):391–400.
  • Jaeschke H, Ramachandran A, Chao X, Ding WX. 2019. Emerging and established modes of cell death during acetaminophen-induced liver injury. Arch Toxicol. 93(12):3491–3502.
  • Jaeschke H, Ramachandran A. 2020. Does JNK regulate acetaminophen hepatotoxicity by modulating Nrf2-dependent genes or mitochondrial oxidant stress? Hepatology. DOI:10.1002/hep.31442.
  • Jaeschke H. 1990. Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther. 255(3):935–941.
  • James L, Simon M, Capparelli E, Hinson J, Davern T, Lee W. 2007. Pharmacokinetic analysis of acetaminophen protein adducts in adults with acute liver failure. Clin Pharmacol Ther. 81(Suppl. 1):2.
  • James LP, Farrar HC, Sullivan JE, Givens TG, Kearns GL, Wasserman GS, Walson PD, Hinson JA, Pumford NR. 2001. Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. Pediatric Pharmacology Research Unit Network, NICHD. J Clin Pharmacol. 41(8):846–851.
  • James LP, Lamps LW, McCullough S, Hinson JA. 2003. Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun. 309(4):857–863.
  • James LP, Letzig L, Simpson PM, Capparelli E, Roberts DW, Hinson JA, Davern TJ, Lee WM. 2009. Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos. 37(8):1779–1784.
  • James LP, Mayeux PR, Hinson JA. 2003. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 31(12):1499–1506.
  • James LP, McCullough SS, Knight TR, Jaeschke H, Hinson JA. 2003. Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress. Free Radic Res. 37(12):1289–1297.
  • Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. 1973. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 187(1):195–202.
  • Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. 1974. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 11(3):151–169.
  • Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, Pohl LR. 2002. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol. 15(12):1504–1513.
  • Kang AM, Padilla-Jones A, Fisher ES, Akakpo JY, Jaeschke H, Rumack BH, Gerkin RD, Curry SC. 2020. The effect of 4-methylpyrazole on oxidative metabolism of acetaminophen in human volunteers. J Med Toxicol. 16(2):169–176.
  • Kaplowitz N, Aw TY, Simon FR, Stolz A. 1986. Drug-induced hepatotoxicity. Ann Intern Med. 104(6):826–839.
  • Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. 2002. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 287(3):337–344.
  • Kayano K, Yasunaga M, Kubota M, Takenaka K, Mori K, Yamashita A, Kubo Y, Sakaida I, Okita K, Sanuki K. 1992. Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure. Liver. 12(3):132–136.
  • Kheradpezhouh E, Barritt GJ, Rychkov GY. 2016. Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 7:1–7.
  • Kleinschmidt D, Giannou AD, McGee HM, Kempski J, Steglich B, Huber FJ, Ernst TM, Shiri AM, Wegscheid C, Tasika E, et al. 2017. A protective function of IL-22BP in ischemia reperfusion and acetaminophen-induced liver injury. J Immunol. 199(12):4078–4090.
  • Knight TR, Fariss MW, Farhood A, Jaeschke H. 2003. Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice. Toxicol Sci. 76(1):229–236.
  • Knight TR, Ho YS, Farhood A, Jaeschke H. 2002. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther. 303(2):468–475.
  • Kon K, Ikejima K, Okumura K, Aoyama T, Arai K, Takei Y, Lemasters JJ, Sato N. 2007. Role of apoptosis in acetaminophen hepatotoxicity. J Gastroenterol Hepatol. 22(Suppl. 1):S49–S52.
  • Kon K, Kim JS, Jaeschke H, Lemasters JJ. 2004. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology. 40(5):1170–1179.
  • Kon K, Kim JS, Uchiyama A, Jaeschke H, Lemasters JJ. 2010. Lysosomal iron mobilization and induction of the mitochondrial permeability transition in acetaminophen-induced toxicity to mouse hepatocytes. Toxicol Sci. 117(1):101–108.
  • Koster U, Albrecht D, Kappus H. 1977. Evidence for carbon tetrachloride-induced and ethanol-induced lipid peroxidation in vivo demonstrated by ethane production in mice and rats. Toxicol Appl Pharmacol. 41(3):639–648.
  • Laskin DL, Gardner CR, Price VF, Jollow DJ. 1995. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 21(4):1045–1050.
  • Laskin DL, Pilaro AM, Ji S. 1986. Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. Toxicol Appl Pharmacol. 86(2):216–226.
  • Laskin DL, Pilaro AM. 1986. Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol Appl Pharmacol. 86(2):204–215.
  • Latchoumycandane C, Goh CW, Ong MM, Boelsterli UA. 2007. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology. 45(2):412–421.
  • Lauterburg BH, Corcoran GB, Mitchell JR. 1983. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest. 71(4):980–991.
  • Lauterburg BH, Mitchell JR. 1987. Therapeutic doses of acetaminophen stimulate the turnover of cysteine and glutathione in man. J Hepatol. 4(2):206–211.
  • Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H. 2000. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci. 54(2):509–516.
  • Lee SM, Cho TS, Kim DJ, Cha YN. 1999. Protective effect of ethanol against acetaminophen-induced hepatotoxicity in mice: role of NADH:quinone reductase. Biochem Pharmacol. 58(10):1547–1555.
  • Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. 1996. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem. 271(20):12063–12067.
  • Lim SP, Andrews FJ, O'Brien PE. 1995. Acetaminophen-induced microvascular injury in the rat liver: protection with misoprostol. Hepatology. 22(6):1776–1781.
  • Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S. 1996. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J. 314(3):877–880.
  • LoGuidice A, Boelsterli UA. 2011. Acetaminophen overdose-induced liver injury in mice is mediated by peroxynitrite independently of the cyclophilin D-regulated permeability transition. Hepatology. 54(3):969–978.
  • Lutkewitte AJ, Schweitzer GG, Kennon-McGill S, Clemens MM, James LP, Jaeschke H, Finck BN, McGill MR. 2018. Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration. Food Chem Toxicol. 115:273–283.
  • MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. 1996. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. 93(21):11853–11858.
  • Macmillan-Crow LA, Cruthirds DL. 2001. Invited review: manganese superoxide dismutase in disease. Free Radic Res. 34(4):325–336.
  • Masubuchi Y, Suda C, Horie T. 2005. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol. 42(1):110–116.
  • Matthews AM, Roberts DW, Hinson JA, Pumford NR. 1996. Acetaminophen-induced hepatotoxicity. Analysis of total covalent binding vs. specific binding to cysteine. Drug Metab Dispos. 24(11):1192–1196.
  • McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. 1980. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA. 244(3):251–253.
  • McCuskey RS. 2006. Sinusoidal endothelial cells as an early target for hepatic toxicants. Clin Hemorheol Microcirc. 34(1–2):5–10.
  • McGill MR, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30(9):2174–2187.
  • McGill MR, Lebofsky M, Norris HR, Slawson MH, Bajt ML, Xie Y, Williams CD, Wilkins DG, Rollins DE, Jaeschke H. 2013. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose–response, mechanisms, and clinical implications. Toxicol Appl Pharmacol. 269(3):240–249.
  • McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. 2012. The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest. 122(4):1574–1583.
  • McGill MR, Staggs VS, Sharpe MR, Lee WM, Jaeschke H. 2014. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology. 60(4):1336–1345.
  • McGill MR, Williams CD, Xie Y, Ramachandran A, Jaeschke H. 2012. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol. 264(3):387–394.
  • McGill MR, Yan HM, Ramachandran A, Murray GJ, Rollins DE, Jaeschke H. 2011. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology. 53(3):974–982.
  • Mehendale HM. 2005. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol. 33(1):41–51.
  • Mehendale HM. 2012. Once initiated, how does toxic tissue injury expand? Trends Pharmacol Sci. 33(4):200–206.
  • Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. 1999. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. 30(1):186–195.
  • Miller BA, Cheung JY. 2016. TRPM2 protects against tissue damage following oxidative stress and ischaemia-reperfusion. J Physiol. 594(15):4181–4191.
  • Miller JA, Miller EC. 1975. Metabolic activation and reactivity of chemical carcinogens. Mutat Res. 33(1 Spec No.):25–26.
  • Miller MG, Jollow DJ. 1984. Effect of l-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Drug Metab Dispos. 12(3):271–279.
  • Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. 1973. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 187:185–194.
  • Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. 1973. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 187(1):211–217.
  • Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. 1974. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 16(4):676–684.
  • Morgan ET, Koop DR, Coon MJ. 1983. Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem Biophys Res Commun. 112(1):8–13.
  • Morrison EE, Oatey K, Gallagher B, Grahamslaw J, O'Brien R, Black P, Oosthuyzen W, Lee RJ, Weir CJ, Henriksen D, et al. 2019. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial). EBioMedicine. 46:423–430.
  • Muldrew KL, James LP, Coop L, McCullough SS, Hendrickson HP, Hinson JA, Mayeux PR. 2002. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos. 30(4):446–451.
  • Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A, Sakamoto K, Ogura K, Noguchi T, Karin M, et al. 2008. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology. 135(4):1311–1321.
  • Napirei M, Basnakian AG, Apostolov EO, Mannherz HG. 2006. Deoxyribonuclease 1 aggravates acetaminophen-induced liver necrosis in male CD-1 mice. Hepatology. 43(2):297–305.
  • Nebert DW, Thorgeirsson SS, Lambert GH. 1976. Genetic aspects of toxicity during development. Environ Health Perspect. 18:35–45.
  • Nelson SD, Dahlin DC, Rauckman EJ, Rosen GM. 1981. Peroxidase-mediated formation of reactive metabolites of acetaminophen. Mol Pharmacol. 20(1):195–199.
  • Ni HM, Bockus A, Boggess N, Jaeschke H, Ding WX. 2012. Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology. 55(1):222–232.
  • Ni HM, Boggess N, McGill MR, Lebofsky M, Borude P, Apte U, Jaeschke H, Ding WX. 2012. Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci. 127(2):438–450.
  • Ni HM, McGill MR, Chao X, Du K, Williams JA, Xie Y, Jaeschke H, Ding WX. 2016. Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. J Hepatol. 65(2):354–362.
  • Ni HM, Williams JA, Jaeschke H, Ding WX. 2013. Zonated induction of autophagy and mitochondrial spheroids limits acetaminophen-induced necrosis in the liver. Redox Biol. 1(1):427–432.
  • Nicotera P, Bellomo G, Orrenius S. 1992. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol. 32:449–470.
  • Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. 2006. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun. 339(1):79–88.
  • Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS. 1993. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 6(4):511–518.
  • Peterson FJ, Holloway DE, Erickson RR, Duquette PH, McClain CJ, Holtzman JL. 1980. Ethanol induction of acetaminophen toxicity and metabolism. Life Sci. 27(18):1705–1711.
  • Potter DW, Hinson JA. 1987a. The 1-electron and 2-electron oxidation of acetaminophen catalyzed by prostaglandin-h synthase. J Biol Chem. 262(3):974–980.
  • Potter DW, Hinson JA. 1987b. Mechanisms of acetaminophen oxidation to n-acetyl-p-benzoquinone imine by horseradish-peroxidase and cytochrome-p-450. J Biol Chem. 262(3):966–973.
  • Potter DW, Miller DW, Hinson JA. 1985. Identification of acetaminophen polymerization products catalyzed by horseradish-peroxidase. J Biol Chem. 260(22):2174–2180.
  • Potter WZ, Davis DC, Mitchell JR, Jollow DJ, Gillette JR, Brodie BB. 1973. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 187(1):203–210.
  • Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. 1979. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ. 2(6198):1097–1100.
  • Prescott LF, Roscoe P, Wright N, Brown SS. 1971. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet. 1(7698):519–522.
  • Prescott LF. 2000. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 49(4):291–301.
  • Proudfoot AT, Wright N. 1970. Acute paracetamol poisoning. Br Med J. 3(5722):557–558.
  • Pumford NR, Hinson JA, Benson RW, Roberts DW. 1990. Immunoblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol Appl Pharmacol. 104(3):521–532.
  • Pumford NR, Hinson JA, Potter DW, Rowland KL, Benson RW, Roberts DW. 1989. Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice. J Pharmacol Exp Ther. 248(1):190–196.
  • Pumford NR, Martin BM, Hinson JA. 1992. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem Biophys Res Commun. 182(3):1348–1355.
  • Radi R, Beckman JS, Bush KM, Freeman BA. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 266(7):4244–4250.
  • Ramachandran A, Lebofsky M, Baines CP, Lemasters JJ, Jaeschke H. 2011. Cyclophilin D deficiency protects against acetaminophen-induced oxidant stress and liver injury. Free Radic Res. 45(2):156–164.
  • Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, Jaeschke H. 2013. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology. 58(6):2099–2108.
  • Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB. 1993. Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J. 7(5):453–463.
  • Ray SD, Mumaw VR, Raje RR, Fariss MW. 1996. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther. 279(3):1470–1483.
  • Ray SD, Sorge CL, Raucy JL, Corcoran GB. 1990. Early loss of large genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury. Toxicol Appl Pharmacol. 106(2):346–351.
  • Ray SD, Sorge CL, Tavacoli A, Raucy JL, Corcoran GB. 1991. Extensive alteration of genomic DNA and rise in nuclear Ca2+ in vivo early after hepatotoxic acetaminophen overdose in mice. Adv Exp Med Biol. 283(699):699–705.
  • Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. 2005. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 312(2):509–516.
  • Reiter CD, Teng RJ, Beckman JS. 2000. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem. 275(42):32460–32466.
  • Roberts DW, Benson RW, Pumford NR, Potter DW, Poulsen HE, Hinson JA. 1991. Sensitive immunochemical assays for monitoring acetaminophen toxicity in humans. In: Vanderlaan M, Stanker LH, Watkins BE, editors. Immunoassays for trace chemical analysis: monitoring toxic chemicals in humans, food and the environment. Washington (DC): American Chemical Society; p. 314–326.
  • Roberts DW, Bucci TJ, Benson RW, Warbritton AR, McRae TA, Pumford NR, Hinson JA. 1991. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)-acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol. 138(2):359–371.
  • Roberts DW, Pumford NR, Potter DW, Benson RW, Hinson JA. 1987. A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther. 241(2):527–533.
  • Rose PG. 1969. Paracetamol overdose and liver damage. Br Med J. 1(5640):381–382.
  • Rumack BH, Peterson RC, Koch GG, Amara IA. 1981. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 141(3 Spec No.):380–385.
  • Rumack BH, Peterson RG. 1978. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics. 62(5 Pt 2 Suppl.):898–903.
  • Rumack BH. 2002. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol. 40(1):3–20.
  • Rumack BH. 2004. Acetaminophen misconceptions. Hepatology. 40(1):10–15.
  • Saito C, Lemasters JJ, Jaeschke H. 2010. c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 246(1–2):8–17.
  • Schmidt LE, Dalhoff K, Poulsen HE. 2002. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology. 35(4):876–882.
  • Schmidt LE, Dalhoff K. 2005. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology. 41(1):26–31.
  • Schopfer F, Riobo N, Carreras MC, Alvarez B, Radi R, Boveris A, Cadenas E, Poderoso JJ. 2000. Oxidation of ubiquinol by peroxynitrite: implications for protection of mitochondria against nitrosative damage. Biochem J. 349(Pt 1):35–42.
  • Schror K. 2007. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs. 9(3):195–204.
  • Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. 1986. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med. 104(3):399–404.
  • Sharma M, Gadang V, Jaeschke A. 2012. Critical role for mixed-lineage kinase 3 in acetaminophen-induced hepatotoxicity. Mol Pharmacol. 82(5):1001–1007.
  • Shen W, Kamendulis LM, Ray SD, Corcoran GB. 1992. Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: effects of Ca2+-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol Appl Pharmacol. 112(1):32–40.
  • Sinclair J, Jeffery E, Wrighton S, Kostrubsky V, Szakacs J, Wood S, Sinclair P. 1998. Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A. Biochem Pharmacol. 55(10):1557–1565.
  • Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. 1988. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 319(24):1557–1562.
  • Smith GS, Nadig DE, Kokoska ER, Solomon H, Tiniakos DG, Miller TA. 1998. Role of neutrophils in hepatotoxicity induced by oral acetaminophen administration in rats. J Surg Res. 80(2):252–258.
  • Streeter AJ, Dahlin DC, Nelson SD, Baillie TA. 1984. The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. Chem Biol Interact. 48(3):349–366.
  • Strehler EE, Zacharias DA. 2001. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev. 81(1):21–50.
  • Sumoza-Toledo A, Penner R. 2011. TRPM2: a multifunctional ion channel for calcium signalling. J Physiol. 589(Pt 7):1515–1525.
  • Tee LB, Boobis AR, Huggett AC, Davies DS. 1986. Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiothreitol. Toxicol Appl Pharmacol. 83(2):294–314.
  • Thompson RP, Clark R, Willson RA, Borirakchanyavat V, Widdop B, Goulding R, Williams R. 1972. Hepatic damage from overdose of paracetamol. Gut. 13(10):836.
  • Thomson JS, Prescott LF. 1966. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J. 2(5512):506–507.
  • Thummel KE, Slattery JT, Nelson SD, Lee CA, Pearson PG. 1989. Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicol Appl Pharmacol. 100(3):391–397.
  • Tirmenstein MA, Nelson SD. 1989. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver. J Biol Chem. 264(17):9814–9819.
  • Tsokos KJ. 1989. Evidence in vivo for elevation of intracellular free Ca2+ in the liver after diquat, acetaminophen, and CCl4. Biochem Pharmacol. 38(18):3061–3065.
  • Tsokos-Kuhn JO, Hughes H, Smith CV, Mitchell JR. 1988. Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. Biochem Pharmacol. 37(11):2125–2131.
  • Vandonselaar M, Hickie RA, Quail JW, Delbaere LTJ. 1994. Trifluoperazine-induced conformational change in Ca2+-calmodulin. Nat Struct Biol. 1(11):795–801.
  • Vendemiale G, Grattagliano I, Altomare E, Turturro N, Guerrieri F. 1996. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem Pharmacol. 52(8):1147–1154.
  • Volak LP, Ghirmai S, Cashman JR, Court MH. 2008. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos. 36(8):1594–1605.
  • von Mering J. 1893. Beitrage zur kenntniss der Antipyretica. Ther Monatsh. 7:577–587.
  • Walker RM, Racz WJ, McElligott TF. 1980. Acetaminophen-induced hepatotoxicity in mice. Lab Invest. 42(2):181–189.
  • Walker RM, Racz WJ, McElligott TF. 1983. Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am J Pathol. 113(3):321–330.
  • Walker RM, Racz WJ, McElligott TF. 1985. Acetaminophen-induced hepatotoxic congestion in mice. Hepatology. 5(2):233–240.
  • Wang H, Ni HM, Chao X, Ma X, Rodriguez YA, Chavan H, Wang S, Krishnamurthy P, Dobrowsky R, Xu DX, et al. 2019. Double deletion of PINK1 and Parkin impairs hepatic mitophagy and exacerbates acetaminophen-induced liver injury in mice. Redox Biol. 22:101148.
  • Webster PA, Roberts DW, Benson RW, Kearns GL. 1996. Acetaminophen toxicity in children: diagnostic confirmation using a specific antigenic biomarker. J Clin Pharmacol. 36(5):397–402.
  • Weis M, Kass GE, Orrenius S. 1994. Further characterization of the events involved in mitochondrial Ca2+ release and pore formation by prooxidants. Biochem Pharmacol. 47(12):2147–2156.
  • Weis M, Kass GEN, Orrenius S, Moldeus P. 1992. N-acetyl-p-benzoquinone imine induces Ca2+ release from mitochondria by stimulating pyridine nucleotide hydrolysis. J Biol Chem. 267(2):804–809.
  • West PR, Harman LS, Josephy PD, Mason RP. 1984. Acetaminophen: enzymatic formation of a transient phenoxyl free radical. Biochem Pharmacol. 33(18):2933–2936.
  • Williams CD, Antoine DJ, Shaw PJ, Benson C, Farhood A, Williams DP, Kanneganti TD, Park BK, Jaeschke H. 2011. Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury. Toxicol Appl Pharmacol. 252(3):289–297.
  • Williams CD, McGill MR, Farhood A, Jaeschke H. 2013. Fas receptor-deficient lpr mice are protected against acetaminophen hepatotoxicity due to higher glutathione synthesis and enhanced detoxification of oxidant stress. Food Chem Toxicol. 58:228–235.
  • Win S, Min RW, Chen CQ, Zhang J, Chen Y, Li M, Suzuki A, Abdelmalek MF, Wang Y, Aghajan M, et al. 2019. Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury. J Clin Invest. 129(12):5278–5293.
  • Win S, Than TA, Han D, Petrovic LM, Kaplowitz N. 2011. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 286(40):35071–35078.
  • Win S, Than TA, Min RW, Aghajan M, Kaplowitz N. 2016. c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src. Hepatology. 63(6):1987–2003.
  • Woolbright BL, Jaeschke H. 2017. Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure. J Hepatol. 66(4):836–848.
  • Woolbright BL, Jaeschke H. 2018. Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity. Curr Pharmacol Rep. 4(5):346–357.
  • Xie Y, McGill MR, Dorko K, Kumer SC, Schmitt TM, Forster J, Jaeschke H. 2014. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol Appl Pharmacol. 279(3):266–274.
  • Xie Y, McGill MR, Du K, Dorko K, Kumer SC, Schmitt TM, Ding WX, Jaeschke H. 2015. Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes. Toxicol Appl Pharmacol. 289(2):213–222.
  • Xie Y, Ramachandran A, Breckenridge DG, Liles JT, Lebofsky M, Farhood A, Jaeschke H. 2015. Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. Toxicol Appl Pharmacol. 286(1):1–9.
  • Yamamoto H. 1990. Antagonism of acetaminophen-induced hepatocellular destruction by trifluoperazine in mice. Pharmacol Toxicol. 67(2):115–119.
  • Yip L, Heard K. 2016. Potential adjunct treatment for high-risk acetaminophen overdose. Clin Toxicol (Phila). 54(5):459.
  • Zaher H, Buters JT, Ward JM, Bruno MK, Lucas AM, Stern ST, Cohen SD, Gonzalez FJ. 1998. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol Appl Pharmacol. 152(1):193–199.
  • Zell-Kanter M, Coleman P, Whiteley PM, Leikin JB. 2013. A gargantuan acetaminophen level in an acidemic patient treated solely with intravenous N-acetylcysteine. Am J Ther. 20(1):104–106.
  • Zhang YF, He W, Zhang C, Liu XJ, Lu Y, Wang H, Zhang ZH, Chen X, Xu DX. 2014. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett. 225(3):445–453.
  • Zhao P, Slattery JT. 2002. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics. Drug Metab Dispos. 30(12):1413–1417.
  • Zimmerman HJ, Maddrey WC. 1995. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 22(3):767–773.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.